In this issue:
Chemo-immunotherapy after anti-PD-1 failure improves outcomes in metastatic melanoma
RFS as a surrogate for OS in adjuvant ICI therapy of melanoma
Survival outcomes of patients with advanced MM
Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system
Prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve stage III CM
SOX10 is as specific as S100 protein in detecting metastases of melanoma in LNs
Polygenic risk and sun exposure in melanoma
Serum vitamin D level and risk and prognosis of melanoma
Please login below to download this issue (PDF)